Filed: 8/14/2024ACC: 0001104659-24-089377
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $118.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$118.74M
Total AUM (reported)
13.01M
Total Shares
Allocation by class
COM$96.46M81.2%
COM SHS$5.22M4.4%
COM PAR $.01$4.83M4.1%
COM NEW$3.48M2.9%
SPON ADS$2.44M2.1%
COMMON STOCK$2.33M2.0%
CL A ORD SHS$1.82M1.5%
Portfolio Concentration
Top 3$36.59M30.8%
4–10$40.96M34.5%
11–25$38.45M32.4%
Rest$2.75M2.3%
Top 3 weight
30.8%
Top 10 weight
65.3%
Voting Authority Distribution
Total shares with voting rights: 13.01M
Sole
Full voting authority
13.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
OCULAR THERAPEUTIX INC
SOLEShares2.77M
TypeSH
Market value$18.95M
15.96%
Sole
2.77M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares397.70K
TypeSH
Market value$9.29M
7.83%
Sole
397.70K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares110.40K
TypeSH
Market value$8.34M
7.02%
Sole
110.40K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares212.50K
TypeSH
Market value$7.50M
6.32%
Sole
212.50K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares164.43K
TypeSH
Market value$6.80M
5.73%
Sole
164.43K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS
SOLEShares135.14K
TypeSH
Market value$6.05M
5.10%
Sole
135.14K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares250.37K
TypeSH
Market value$5.39M
4.54%
Sole
250.37K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares2.33M
TypeSH
Market value$5.22M
4.40%
Sole
2.33M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares133K
TypeSH
Market value$5.16M
4.35%
Sole
133K
Shared
0.00
None
0.00
INSMED INC
SOLEShares72.10K
TypeSH
Market value$4.83M
4.07%
Sole
72.10K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares27.50K
TypeSH
Market value$4.34M
3.66%
Sole
27.50K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares269.61K
TypeSH
Market value$3.47M
2.92%
Sole
269.61K
Shared
0.00
None
0.00
AGIOS PHARMA
SOLEShares78.70K
TypeSH
Market value$3.39M
2.86%
Sole
78.70K
Shared
0.00
None
0.00
KURA ONCOLOGY INC. COMMON STOCK
SOLEShares163K
TypeSH
Market value$3.36M
2.83%
Sole
163K
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares1.66M
TypeSH
Market value$3.34M
2.82%
Sole
1.66M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HOLDI
SOLEShares64.50K
TypeSH
Market value$2.92M
2.46%
Sole
64.50K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$2.70M
2.27%
Sole
1.85M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares199.43K
TypeSH
Market value$2.59M
2.19%
Sole
199.43K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares369.28K
TypeSH
Market value$2.51M
2.12%
Sole
369.28K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PL-ADR
SOLEShares677K
TypeSH
Market value$2.44M
2.05%
Sole
677K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares42.20K
TypeSH
Market value$2.33M
1.96%
Sole
42.20K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares177.84K
TypeSH
Market value$1.82M
1.53%
Sole
177.84K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares4K
TypeSH
Market value$1.72M
1.45%
Sole
4K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares260K
TypeSH
Market value$774.8K
0.65%
Sole
260K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares45K
TypeSH
Market value$737.1K
0.62%
Sole
45K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX INCSOLE | COM | 2.77M | SH | $18.95M 15.96% | 2.77M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 397.70K | SH | $9.29M 7.83% | 397.70K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 110.40K | SH | $8.34M 7.02% | 110.40K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 212.50K | SH | $7.50M 6.32% | 212.50K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 164.43K | SH | $6.80M 5.73% | 164.43K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALSSOLE | COM | 135.14K | SH | $6.05M 5.10% | 135.14K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 250.37K | SH | $5.39M 4.54% | 250.37K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 2.33M | SH | $5.22M 4.40% | 2.33M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 133K | SH | $5.16M 4.35% | 133K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 72.10K | SH | $4.83M 4.07% | 72.10K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 27.50K | SH | $4.34M 3.66% | 27.50K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 269.61K | SH | $3.47M 2.92% | 269.61K | 0.00 | 0.00 |
AGIOS PHARMASOLE | COM | 78.70K | SH | $3.39M 2.86% | 78.70K | 0.00 | 0.00 |
KURA ONCOLOGY INC. COMMON STOCKSOLE | COM | 163K | SH | $3.36M 2.83% | 163K | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 1.66M | SH | $3.34M 2.82% | 1.66M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HOLDISOLE | COM NEW | 64.50K | SH | $2.92M 2.46% | 64.50K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $2.70M 2.27% | 1.85M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 199.43K | SH | $2.59M 2.19% | 199.43K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 369.28K | SH | $2.51M 2.12% | 369.28K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PL-ADRSOLE | SPON ADS | 677K | SH | $2.44M 2.05% | 677K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 42.20K | SH | $2.33M 1.96% | 42.20K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 177.84K | SH | $1.82M 1.53% | 177.84K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 4K | SH | $1.72M 1.45% | 4K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 260K | SH | $774.8K 0.65% | 260K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 45K | SH | $737.1K 0.62% | 45K | 0.00 | 0.00 |
Page 1 of 2